Clinical trial
A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent…
NCT00038714 · Nventa Biopharmaceuticals Corporation, Industry · Completed
Key facts
| NCT number | NCT00038714 |
|---|---|
| Title | A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis |
| Official title | A Phase II Trial of SGN-00101 In The Treatment of Pediatric Recurrent Respiratory Papillomatosis |
| Lead sponsor | Nventa Biopharmaceuticals Corporation, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Papilloma, Recurrent Respiratory Papillomatosis |
| Intervention type | Drug |
| Interventions | SGN-00101 |
| Enrollment | 27 |
| Start date | Nov 1, 2001 |
| Completion | Jan 1, 2004 |
| First posted | Jun 5, 2002 |
| Last update posted | Jun 27, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: